BioSpace News Archive

Natural Alternatives International, Inc. announced net income of $6.7 million, or $0.95 per diluted share, on net sales of $108.0 million for the nine months ended March 31, 2019.

Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency (RF) ablation, demonstrated safety and efficacy in achieving pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF) in QDOT-FAST,** the first in-human multicenter study of the device

Bausch Health Companies Inc. announced that it has priced its previously announced offering of $750,000,000 aggregate principal amount of 7.000% senior notes due 2028 and $750,000,000 aggregate principal amount of 7.250% senior notes due 2029.

resTORbio, Inc. (Nasdaq: TORC), today announced the initiation of PROTECTOR 1, the first Phase 3 trial of RTB101, an orally administered, small molecule, potent inhibitor of target of rapamycin complex 1 (TORC1)

NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced the selection of Seoul-based DAON BioSciences as exclusive distributor in the South Korea market.

SALT LAKE CITY, May 9, 2019 – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that the EndoPredict® test (EPclin) identifies women with early-stage breast cancer who can safely forgo extended endocrine therapy five years after diagnosis.

Aiming to simplify and speed up complicated radiology workflows, NVIDIA and King’s College London today announced they are partnering to build an AI platform that will in the near future allow specialists in the U.K.’s National Health Service (NHS) to train computers to automate the most time-consuming part of radiology interpretation.

In the recently published 2018 annual report, Watson-Marlow Fluid Technology Group (WMFTG), a Spirax-Sarco Engineering Company, reported excellent sales of over £265 million, driven by the continued growth of key industries as well as aggressive overseas expansion.

Greenbrook TMS Inc. is pleased to announce the expansion of its TMS Center network into the State of Michigan.

Acceleron Pharma Inc. provided a corporate update and reported financial results for the first quarter ended March 31, 2019.